Does ROSUVASTATIN Cause Product substitution issue? 395 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 395 reports of Product substitution issue have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 1.1% of all adverse event reports for ROSUVASTATIN.
395
Reports of Product substitution issue with ROSUVASTATIN
1.1%
of all ROSUVASTATIN reports
0
Deaths
44
Hospitalizations
How Dangerous Is Product substitution issue From ROSUVASTATIN?
Of the 395 reports, 44 (11.1%) required hospitalization.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 395 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which ROSUVASTATIN Alternatives Have Lower Product substitution issue Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN